We and others have reported that the breast cancer risk fraction contributed by missense variants in BRCA1, BRCA2, ATM and CHEK2 is as high, if not higher, than protein-truncating variants in these genes [46–48]. The gene discussed is BRCA1; the disease is breast cancer.